Page Tools:

Study Guide for Institutional Review Board Management and Function , Second Edition

Author(s): Amy Davis, JD, MPH
Elizabeth A. Bankert, MA, Dartmouth IRB
Karen Hansen
Susan Kornetsky, MPH, CIP
Helen McGough, MA, CIP
Details:
  • ISBN-13: 9780763738662
  • ISBN-10:0763738662
  • Paperback    176 pages      © 2006
Price: International Sales $67.95 US List
Add to Cart

Overview

Published in partnership with the Applied Research Ethics Association (ARENA), this study guide companion to Institutional Review Board: Management and Function, Second Edition facilitates the application of knowledge acquired from the textbook. Written by IRB people for IRB people, this study guide is a useful resource that promotes the professional development of people working in the field of human subjects protection.

ShowTable of Contents

Table of Contents

 

Part 1: Background and Overview Topics

Chapter 1-1 An Ethics Primer for IRB’s

Chapter 1-2 Reflections of an Outsider

Chapter 1-3 A Unified Human-Research Protection Program

Chapter 1-4 A Shared Responsibility to Protect Human Subjects

Chapter 1-5 A Brief History of PRIM&R and IRB Education

Chapter 1-6 The IRB: Definition and Federal Oversight

Chapter 1-7 The Limits of IRB Authority

Part 1 Answer Key

Part 2: Organizing the Office

Chapter 2-1 Administrative Reporting Structure for the IRB

Chapter 2-2 Policies, Procedures and Documenting Compliance with Federal Regulations

Chapter 2-3 Tracking Systems Using Information Technology

Chapter 2-4 Support Staff

Chapter 2-5 Audit Systems

Chapter 2-6 Charging for IRB Review

Part 2 Answer Key

Part 3: Organizing the IRB Committee

Chapter 3-1 Reflections on Chairing an IRB

Chapter 3-2 The IRB Chair

Chapter 3-3 The IRB Administrative Director

Chapter 3-4 The Role of an Attorney

Chapter 3-5 Committee Size, Alternates and Consultants

Chapter 3-6 Length, Frequency and Time of IRB Meetings

Chapter 3-7 IRB Subcommittees

Chapter 3-8 Social Science vs. Biomedical IRBs

Part 3 Answer Key

Part 4: Review Categories Other Than Full Board Review

Chapter 4-1 Exempt from IRB Review

Chapter 4-2 Expedited from IRB Review

Chapter 4-3 Definition of Research

Chapter 4-4 “Compassionate Use” and the Emergency Use Exemption

Chapter 4-5 Waiver of Consent in Emergency Medicine Research

Part 4 Answer Key

Part 5: Initial Protocol Review and the Full-Committee Meeting

Chapter 5-1 Overview of Initial Protocol Review

Chapter 5-2 Evaluating   Study Design and Quality

Chapter 5-3 The Study Population: Women, Minorities and Children

Chapter 5-4 Community Consultation to Assess and Minimize Group Harms

Chapter 5-5 Privacy and Confidentiality  

Chapter 5-6 Recruitment of Research Subjects

Chapter 5-7 Advertisments for Research

Chapter 5-8 Paying Research Subjects

Chapter 5-9 Provisions for Data Monitoring

Chapter 5-10 Conflict of Interest: Researchers

Chapter 5-11 Conflict of Interest: Recruitment Incentives

Chapter 5-12 Conflict of Interest: IRBs

Chapter 5-13 Administrative Tasks Before Each IRB Meeting

Chapter 5-14 Guidelines for Review, Discussion and Voting

Chapter 5-15 Administrative Tasks After Each IRB Meeting

Part 5 Answer Key

Part 6: Informed Consent

Chapter 6-1 The IRB’s Role in Editing the Consent Document

Chapter 6-2 The Consent Document

Chapter 6-3 Exculpatory Language in Informed Consent Documents

Chapter 6-4 Requiring a Witness Signature on the Consent Form

Chapter 6-5 Deception of Research Subjects

Chapter 6-6 Waiving Informed Consent or a Signed Consent Form

Chapter 6-7 Selecting a Surrogate to Consent to Medical Research

Chapter 6-8 Research-Related Injuries

Chapter 6-9 Informing Subjects of Research Results

Chapter 6-10 Explaining the Costs of Research Participation

Chapter 6-11 Improving Informed Consent

Chapter 6-12 Informed Consent Evaluation Feedback Tool

Part 6 Answer Key

Part 7: Continuing Review

Chapter 7-1 Revisions to Approved Protocol

Chapter 7-2 Protocol Renewal

Chapter 7-3 IRB Review of Adverse Events

Chapter 7-4 Data and Safety Monitoring

Chapter 7-5 Noncompliance, Complaints, Deviations, Eligibility Exceptions

Chapter 7-6 Closing Out a Study

Part 7 Answer Key

Part 8: Administrative and Regulatory Issues

Chapter 8-1 HIPAA and Research

Chapter 8-2 OHRP Federal-Wide Assurance

Chapter 8-3 International Conference on Harmonization

Chapter 8-4 Gene Therapy Oversight

Chapter 8-5 Understanding the FDA’s IND Process

Chapter 8-6 Differences Between DHHS and FDA Regulations

Chapter 8-7 Veteran’s Administration Research Guidelines

Chapter 8-8 State Law

Chapter 8-9 IRB Member Liability

Chapter 8-10 Certificate of Confidentiality

Chapter 8-11 Training IRB Members

Chapter 8-12 Investigator Training

Chapter 8-13 Accreditation of an IRB

Chapter 8-14 Certification of IRB Professionals

Chapter 8-15 Preparing for an FDA Audit

Chapter 8-16 Preparing for an OHRP Site Visit

Part 8 Answer Key

Part 9: Issues Based on Study Population

Chapter 9-1 Vulnerability in Research

Chapter 9-2 Research in Public Schools

Chapter 9-3 Phase I Clinical Trials in Health Adults

Chapter 9-4 Requiring Birth Control to Participate in Research

Chapter 9-5 Research Involving Fetuses and In Vitro Fertilization

Chapter 9-6 Research Involving Pregnant Women

Chapter 9-7 Research Involving Children

Chapter 9-8 Research Involving Adults with Decisional Impairment

Chapter 9-9 Regulatory Issues of Research Involving Prisoners

Chapter 9-10 Research Involving College Students

Part 9 Answer Key

Part 10: IRB Issues Based on Study Design or Category

Chapter 10-1 When are Research Risks Reasonable in Relation to Anticipated Benefits

Chapter 10-2 Internet Research: A Brief Guide for IRBs

Chapter 10-3 Qualitative Social Science Research

Chapter 10-4 Ethnographic Research

Chapter 10-5 Health Services Research

Chapter 10-6 Epidemiology/Public Health Research

Chapter 10-7 Survey Research

Chapter 10-8 Research Involving A Medical Device

Chapter 10-9 Humanitarian Use Devices

Chapter 10-10 Banking of Biological Materials Research

Chapter 10-11 The Placebo-Controlled Clinical Trial

Chapter 10-12 Treatment-Withholding Studies in Psychiatry

Chapter 10-13 Phase I Oncology Trials

Chapter 10-14 Research Involving Genetic Testing

Chapter 10-15 International Research

Chapter 10-16 Alternative Medicine Research

Part 10 Answer Key

Part 11: Reference Material and Contact Information
Ch 11-1B The Belmont Report
Ch 11-1C World Medical Association Declaration of Helsinki

Part 11 Answer Key


Back to top

ShowAbout the Author(s)

Amy Davis, JD, MPH

Elizabeth A. Bankert, MA-Dartmouth IRB

Elizabeth Bankert has been the Administrative Director of the IRB at Dartmouth College/Dartmouth Hitchcock Medical Center for ten years. She is a past president of Applied Research Ethics National Association (ARENA), a national membership organization comprised of over 2,000 IRB professionals, members, and researchers. Liz has made numerous presentations at institutions throughout the country as an invited speaker on topics ranging from Adverse Event Report to Research Involving Incompetent Patients.

Liz's most recent endeavor is a collaboration with Robert (Skip) Nelson, MD at Children's Hospital of Philadelphia in the creation of a web-based site referred to as IRBNet. The primary mission of IRBNet is to create an effective and efficient means of education and communication between sponsors, IRBs, and researchers with the goal of enhancing and streamlining the processes involved with research involving human subjects. IRBNet can be found at www.irbnet.org.

Additional Titles by this Author

Karen Hansen

Susan Kornetsky, MPH, CIP

Helen McGough, MA, CIP

Back to top